Cardiovascular Disease In Aids Book in PDF, ePub and Kindle version is available to download in english. Read online anytime anywhere directly from your device. Click on the download button below to get a free pdf file of Cardiovascular Disease In Aids book. This book definitely worth reading, it is an incredibly well-written.
Cardiovascular Disease in AIDS by Giuseppe Barbaro,Franck Boccara Pdf
This book focuses on some of the new clinical and biological insights related to HIV-associated metabolic and cardiovascular complications in the HAART era. The introduction of highly active antiretroviral therapy (HAART) has altered cardiovascular manifestations in HIV. On the one hand, HAART has significantly improved the quality of life of HIV-infected patients. On the other hand, the early data have raised some concerns, creating an intriguing clinical scenery.
HIV Infection and the Cardiovascular System by Giuseppe Barbaro Pdf
Past studies revealed that HIV infection may implicate diverse cardiac diseases such as cardiomyopathy, coronary heart disease, cardiac neoplasms, endocarditis or pericarditis. In addition, it was found that highly active antiretroviral therapy (HAART) often causes - as an adverse effect - a metabolic syndrome characterized by lipodystrophy/lipoatrophy, dyslipidemia and insulin resistance, leading to an increase in coronary artery disease and stroke. This book focuses on the most recent findings in HIV-associated heart disease and HAART-associated metabolic and cardiovascular complications. In a first part, the epidemiology, pathogenesis and molecular biology of HIV-associated cardiovascular disease, pulmonary hypertension, lipodystrophy and HAART-associated metabolic syndrome are reviewed. The second part offers clinical and therapeutic insights into HIV/HAART-associated atherosclerosis, coronary heart disease, stroke, vasculitic syndromes, and pulmonary hypertension. Besides, cardiovascular complications in HIV-infected children, cardiac surgery in HIV-infected patients, and the prevention and management of HAART-associated cardiovascular complications are points under discussion. Finally, the interaction between HAART and drugs commonly used to treat cardiovascular disease is carefully analyzed. HIV Infection and the Cardiovascular System presents state-of-the-art findings of basic and clinical scientists and is a valuable reference for specialists in cardiology and internal medicine as well as for infectiologists.
Cardiovascular Disease in AIDS by Giuseppe Barbaro,Franck Boccara Pdf
Studies published before the introduction of highly active antiretroviral therapy (HAART) tracked the incidence and course of HIV infection in relation to cardiac illness in both children and adults. These studies show that subclinical echocardiographic abnormalities independently predict adverse outcomes and identify high-risk groups to be targeted for early intervention and therapy. The introduction of HAART has altered cardiovascular manifestations in HIV. On the one hand, HAART has significantly modified the course of HIV disease, lengthened survival, and improved the quality of life of HIV-infected patients. On the other hand, the early data have raised concerns that HAART is associated with an increase in both peripheral and coronary arterial diseases, creating an intriguing clinical scenery. This book focuses on new clinical and biological insight related to HIV-associated metabolic and cardiovascular complications in the HAART era. This second edition wants tonbsp;present the latest developmentsnbsp;and the most updated research data innbsp;this rapidly evolving field.
Cardiovascular Care in Patients With HIV by Merle Myerson,Marshall J. Glesby Pdf
This book provides the most current overview of the evaluation and management of cardiovascular disease in people living with HIV/AIDS. The text assesses the risk factors associated with cardiovascular disease in HIV/AIDS patients and explores the most cutting edge ways to diagnose and treat the specific diseases that are most common for people living with HIV. This text takes a well-rounded, multidisciplinary approach that considers infectious disease and HIV specialists who may have little familiarity with the diagnosis and management of manifest CVD or risk factors as well as those in remote areas where providers may have little or no infrastructure to support optimal care for their patients. The text also serves cardiovascular specialists who may not have the expertise in HIV care to meet the unique needs of these patients. Cardiovascular Care for the Patient Living with HIV is the ultimate resource for not only all infectious disease and HIV specialists, but also for cardiologists, neurologists, vascular surgeons, general practitioners, nurse practitioners, physician’s assistants, and all other medical professionals who care for people living with HIV.
Cardiovascular Disease in AIDS by Giuseppe Barbaro,Franck Boccara Pdf
This book focuses on some of the new clinical and biological insights related to HIV-associated metabolic and cardiovascular complications in the HAART era. The introduction of highly active antiretroviral therapy (HAART) has altered cardiovascular manifestations in HIV. On the one hand, HAART has significantly improved the quality of life of HIV-infected patients. On the other hand, the early data have raised some concerns, creating an intriguing clinical scenery.
HIV-associated Cardiovascular Disease by Giuseppe Ippolito Pdf
International specialists examine therapeutic choices for the treatment of myocardial cell dysfunction in HIV disease, with a focus on knowledge in both clinical and biological aspects of HIV-associated cardiovascular disease. Topics covered include research findings from experimental work on transgenic mice; the role of cytokines in the development of HIV-associated cardiomyopathy and pulmonary hypertension (with related diagnostic and therapeutic implications); and the relationship between dilated cardiomyopathy and encephalopathy in HIV-infected adults and children.
HIV and Cardiovascular Risk by Marshall Glesby Pdf
Advances in antiretroviral therapy have led to the expectation that many people living with HIV infection will live for decades. The demographics of the HIV epidemic in the developed world have also shifted in recent years, making older adults an increasing proportion of patients. As a consequence, cardiovascular disease, the major cause of mortality in the general population, has become an important long-term concern in the HIV-infected population as well. Furthermore, there is increasing recognition that HIV and antiretroviral-related factors may contribute to accelerated atherosclerosis in this population. Taken together, these factors suggest that the prevalence of cardiovascular disease in HIV-infected patients will continue to grow in the coming years. There is increasing demand for up-to-date knowledge in the area of cardiovascular disease in HIV-infected patients. The proposed book, HIV and Cardiovascular Risk (Oxford American Pocket Notes), will target both HIV care-providers and cardiologists who regularly treat HIV-infected patients. HIV care-providers must stay current with cardiac issues that affect their patients, and cardiologists must be aware of HIV-specific factors, including drug-drug interactions between cardiac drugs and antiretrovirals, to provide optimal care to these patients. Part of the Oxford American Pocket Note series, this ultra concise handbook covers the full spectrum of cardiovascular disease in HIV-infected patients, but also discusses each topic in proportion to its clinical importance. As such, the majority of the book will be devoted to coronary heart disease risk. Other clinically important cardiac conditions are also addressed, including cardiomyopathy, pericardial effusion, endocarditis, pulmonary hypertension, cardiac tumors, and conduction abnormalities. Using the most up-to-date material available, this guide provides ID specialists, cardiologists and other clinicians with an invaluable evidence-based resource in the proper assessment and management of cardiovascular risks in HIV patients. The portable volume includes evidence-based clinical guidance on the latest diagnostic guidelines, laboratory evaluations and cognitive testing for these prevalent disorders. Outstanding features include numerous illustrations of key concepts and pathways as well as summary tables and charts.
King K. Holmes,Stefano Bertozzi,Barry R. Bloom,Prabhat Jha
Author : King K. Holmes,Stefano Bertozzi,Barry R. Bloom,Prabhat Jha Publisher : World Bank Publications Page : 506 pages File Size : 50,7 Mb Release : 2017-11-06 Category : Medical ISBN : 9781464805257
Disease Control Priorities, Third Edition (Volume 6) by King K. Holmes,Stefano Bertozzi,Barry R. Bloom,Prabhat Jha Pdf
Infectious diseases are the leading cause of death globally, particularly among children and young adults. The spread of new pathogens and the threat of antimicrobial resistance pose particular challenges in combating these diseases. Major Infectious Diseases identifies feasible, cost-effective packages of interventions and strategies across delivery platforms to prevent and treat HIV/AIDS, other sexually transmitted infections, tuberculosis, malaria, adult febrile illness, viral hepatitis, and neglected tropical diseases. The volume emphasizes the need to effectively address emerging antimicrobial resistance, strengthen health systems, and increase access to care. The attainable goals are to reduce incidence, develop innovative approaches, and optimize existing tools in resource-constrained settings.
Institute of Medicine,Board on Global Health,Committee on Preventing the Global Epidemic of Cardiovascular Disease: Meeting the Challenges in Developing Countries
Author : Institute of Medicine,Board on Global Health,Committee on Preventing the Global Epidemic of Cardiovascular Disease: Meeting the Challenges in Developing Countries Publisher : National Academies Press Page : 483 pages File Size : 49,5 Mb Release : 2010-06-29 Category : Medical ISBN : 9780309157612
Promoting Cardiovascular Health in the Developing World by Institute of Medicine,Board on Global Health,Committee on Preventing the Global Epidemic of Cardiovascular Disease: Meeting the Challenges in Developing Countries Pdf
Cardiovascular disease (CVD), once thought to be confined primarily to industrialized nations, has emerged as a major health threat in developing countries. Cardiovascular disease now accounts for nearly 30 percent of deaths in low and middle income countries each year, and is accompanied by significant economic repercussions. Yet most governments, global health institutions, and development agencies have largely overlooked CVD as they have invested in health in developing countries. Recognizing the gap between the compelling evidence of the global CVD burden and the investment needed to prevent and control CVD, the National Heart, Lung, and Blood Institute (NHLBI) turned to the IOM for advice on how to catalyze change. In this report, the IOM recommends that the NHLBI, development agencies, nongovernmental organizations, and governments work toward two essential goals: creating environments that promote heart healthy lifestyle choices and help reduce the risk of chronic diseases, and building public health infrastructure and health systems with the capacity to implement programs that will effectively detect and reduce risk and manage CVD. To meet these goals, the IOM recommends several steps, including improving cooperation and collaboration; implementing effective and feasible strategies; and informing efforts through research and health surveillance. Without better efforts to promote cardiovascular health, global health as a whole will be undermined.
The first reference to collect the latest research and reviews on the treatment and pathogenesis of heart disease in AIDS patients, this reference attempts to improve the diagnosis, management, and therapy of HIV-associated heart failure by studying the prolonged effects of immunosuppression and opportunistic and viral infection, as well as cofactors affecting heart disease such as drug-related cardiotoxicity, cocaine abuse, and nutritional deficiencies on cardiac function.
Advances in HIV and AIDS Control by Samuel Ikwaras Okware Pdf
The HIV epidemic has had a significant and profound impact on the world and health resources. Considerable progress has been made in understanding the risks and drivers of the epidemic. Antiretroviral drugs have relieved human suffering and prolonged life. However, access to quality management needs to scale up and be made universal. This book discusses critical issues related to the treatment of HIV infection and related co-infections and challenges in adherence and discordancy. New vaccine approaches discussed may provide the ultimate solution for eradication. Sharing knowledge from various experts in medical and basic sciences improves the quality of care for this persistent global threat. This book discusses emerging advances in HIV-AIDS management to support strategies for control and elimination.
Management of Dyslipidemia by Wilbert S. Aronow Pdf
Dyslipidemia is a major risk factor for cardiovascular events, cardiovascular mortality, and all-cause mortality. The earlier in life dyslipidemia is treated, the better the prognosis. The current book is an excellent one on dyslipidemia written by experts on this topic. This book includes 12 chapters including 5 on lipids, 4 on hypercholesterolemia in children, and 3 on the treatment of dyslipidemia. This book should be read by all health care professionals taking care of patients, including pediatricians since atherosclerotic cardiovascular disease begins in childhood.
The first reference to collect the latest research and reviews on the treatment and pathogenesis of heart disease in AIDS patients, this reference attempts to improve the diagnosis, management, and therapy of HIV-associated heart failure by studying the prolonged effects of immunosuppression and opportunistic and viral infection, as well as cofactors affecting heart disease such as drug-related cardiotoxicity, cocaine abuse, and nutritional deficiencies on cardiac function.
HIV infection has major consequences for the cardiovascular system and has become one of the leading causes of acquired heart disease. This book has been written to inform the cardiology community about HIV-related cardiovascular complications and to furnish primary care providers with information about cardiac aspects of HIV infection. The text covers all aspects of cardiovascular disease in relation to HIV, including pathology, pharmacology, concerns in children and the elderly, and how complications can affect the fetus. Practical applications of nursing and patient management are also addressed.
Institute of Medicine,Board on the Health of Select Populations,Committee on Social Security HIV Disability Criteria
Author : Institute of Medicine,Board on the Health of Select Populations,Committee on Social Security HIV Disability Criteria Publisher : National Academies Press Page : 217 pages File Size : 42,5 Mb Release : 2010-11-17 Category : Medical ISBN : 9780309177122
HIV and Disability by Institute of Medicine,Board on the Health of Select Populations,Committee on Social Security HIV Disability Criteria Pdf
The Social Security Administration (SSA) uses a screening tool called the Listing of Impairments to identify claimants who are so severely impaired that they cannot work at all and thus qualify for disability benefits. In this report, the Institute of Medicine (IOM) makes several recommendations for improving SSA's capacity for determining disability benefits more accurately and quickly using the HIV Infection Listings.
